Ipsen selects Pierrick Lefranc as new EVP Technical Operations
He brings 30 years of pharma industry experience to the role, principally in key manufacturing projects.
List view / Grid view
He brings 30 years of pharma industry experience to the role, principally in key manufacturing projects.
His appointment comes as the pharma company AstraZeneca seeks to hit $80 billion revenue target by 2030.
She will become the fifth leader at the Center, following the surprise retirement decision by her soon-to-be predecessor Richard Pazdur.
Swiss pharma company to trim production of oral medicines and packaging in Stein, while boosting productivity in Schweizerhalle.
Dr Carole Ho joins from Denali Therapeutics and there are promotions for Adrienne Brown and Daniel Skovronsky.
Cultural change inside pharma needed to help attract tech talent and support a deeper adoption of AI in the industry, say recruiters at CPHI Frankfurt 2025.
The company’s CEO says the shift will help prioritise investment into obesity and diabetes, the company’s leading therapy areas.
Her leadership experience spans three decades with Lilly, across multiple therapeutic areas including oncology, neuroscience and infectious disease.
The new appointee has over twenty years of experience in biopharma and extensive senior expertise in oncology.
Current market conditions in the pharmaceutical industry have driven the change to its executive leadership team, according to Novo Nordisk.
Immigration law experts from Fragomen LLP discuss currently challenges in the UK’s visa system and propose recommendations for attracting science and technology talent that support the country’s competitiveness.
A major overhaul of the UK’s Apprenticeship Levy promises to deliver greater flexibility for pharmaceutical workforce training, helping to address critical skills shortages.
The biopharmaceutical company’s executive transition follows a multi-year succession process to support its next chapter.
The new member of Genmab’s Executive Committee brings over 30 years of international biopharmaceutical experience to the role.
The new members of the Cell and Gene Therapy Catapult’s board hold expertise across therapy development, digitalisation and leadership.